BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yamashita H. Tumor biology in estrogen receptor-positive, human epidermal growth factor receptor type 2-negative breast cancer: Mind the menopausal status. World J Clin Oncol 2015; 6(6): 220-224 [PMID: 26677435 DOI: 10.5306/wjco.v6.i6.220]
URL: https://www.wjgnet.com/2218-4333/full/v6/i6/220.htm
Number Citing Articles
1
Magali Olivier, Liacine Bouaoun, Stephanie Villar, Alexis Robitaille, Vincent Cahais, Adriana Heguy, Graham Byrnes, Florence Le Calvez-Kelm, Gabriela Torres-Mejía, Isabel Alvarado-Cabrero, Fazlollah Shahram Imani-Razavi, Gloria Inés Sánchez, Roberto Jaramillo, Carolina Porras, Ana Cecilia Rodriguez, Maria Luisa Garmendia, José Luis Soto, Isabelle Romieu, Peggy Porter, Jamie Guenthoer, Sabina Rinaldi, Obul Reddy Bandapalli. Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA studyPLOS ONE 2019; 14(1): e0210372 doi: 10.1371/journal.pone.0210372
2
Jiazhi Guo, Aiko Sueta, Koshi Nakamura, Nobuyasu Yoshimoto, Motoi Baba, Naoko Ishida, Kanako Hagio, Tatsuya Toyama, Hirotaka Iwase, Akiko Tamakoshi, Hiroko Yamashita. Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese womenOncotarget 2017; 8(39): 65759 doi: 10.18632/oncotarget.20182
3
William B Coleman. Obesity and the breast cancer methylomeCurrent Opinion in Pharmacology 2016; 31: 104 doi: 10.1016/j.coph.2016.11.006
4
Naoko Ishida, Motoi Baba, Yutaka Hatanaka, Kanako Hagio, Hiromi Okada, Kanako C. Hatanaka, Kenichi Togashi, Yoshihiro Matsuno, Hiroko Yamashita. PIK3CAmutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancerOncotarget 2018; 9(25): 17711 doi: 10.18632/oncotarget.24845